NCT04918134

Brief Summary

Helicobacter pylori can lead to a variety of digestive system diseases.The eradication of Helicobacter pylori plays an importment role for the treatment of gastrointestinal ulcer and prevention of gastric cancer .Compared with other countries and regions in the world, the infection rate of Helicobacter pylori in China can reach more than 50%. The non-standard diagnosis and treatment of Helicobacter pylori greatly reduces its eradication rate and increases its drug resistance.Therefore, it is very important to strengthen the standardization of diagnosis and treatment to improve the eradication rate. The purpose of this study is to investigate the diagnosis and treatment status of Helicobacter pylori among gastroenterologists in general hospitals in Shandong Province.It can help us to understand the actual situation of diagnosis and treatment of Helicobacter pylori in hospitals at all levels, and to provide targeted diagnosis and treatment training for doctors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 2, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 8, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

July 10, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 7, 2021

Completed
Last Updated

October 19, 2021

Status Verified

October 1, 2021

Enrollment Period

1 month

First QC Date

June 2, 2021

Last Update Submit

October 10, 2021

Conditions

Keywords

questionnaireHelicobacter Pylori Infectioncross-sectional survey

Outcome Measures

Primary Outcomes (1)

  • the results of the questionnaires

    the results of each question of the questionnaires

    2 months

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Stratified sampling was carried out from all the secondary and tertiary general hospitals in Shandong province, and 120 hospitals were selected.Exclude those without gastroenterology department and those that refused to sign the informed consent, and all gastroenterologists in the hospitals were investigated.

You may qualify if:

  • All the gastroenterologists in secondary and tertiary general hospitals of Shandong province

You may not qualify if:

  • A hospital that does not include gastroenterology
  • Hospitals and gastroenterologists that refuse to sign informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Qilu hosipital

Jinan, Shandong, 257000, China

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Director of gastroenterology department of Qilu hospital

Study Record Dates

First Submitted

June 2, 2021

First Posted

June 8, 2021

Study Start

July 10, 2021

Primary Completion

August 20, 2021

Study Completion

October 7, 2021

Last Updated

October 19, 2021

Record last verified: 2021-10

Locations